RESEARCH FUNDS IN THE HEALTH SECTOR

1^ST STAGE DEADLINE: OCTOBER 13^th, 2010.

1.     BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH 

• High-throughput research
• Innovative therapeutic approaches and interventions: regenerative medicine clinical trials

2.        TRANSLATING RESEARCH FOR HUMAN HEALTH

• Integrating biological data and processes: large-scale data gathering, systems biology
• Research on the brain and related diseases, human development and ageing
• Translational research in major infectious diseases: to confront major threats to public health 
• antimicrobial drug resistance
• Potentially new and re-emerging epidemics
• Translational research in other major diseases

3. OPTIMISING THE DELIVERY OF HEALTHCARE TO EUROPEAN CITIZENS

• Developing methodologies to reduce inequities in the determinants of health.
• Analysis of integrated strategies for sustainable behaviour change.

 

For further information, please contact infonetwork@igcsas.it

 

RESEARCH FUNDS IN THE HEALTH SECTOR

DEADLINE: NOVEMBER 10^th, 2010

MAIN AREAS OF INTERVENTION:

1.     BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH

a.       High throughput proteomics for human health and disease

b.       High impact research initiative for better immunization

c.       New therapeutic approaches in chronic inflammatory and autoimmune diseases.

  

2.     TRANSLATING RESEARCH FOR HUMAN HEALTH

·         INTEGRATING BIOLOGICAL DATA AND PROCESSES: LARGE-SCALE DATA GATHERING, SYSTEMS BIOLOGY:

a.       High impact research initiative on the human epigenome

b.       Population genetics studies on cardio-metabolic disorders in EU/AC and EECA populations

·         RESEARCH ON THE BRAIN AND RELATED DISEASES, HUMAN DEVELOPMENT AND AGEING

a.       Creating clinical and molecular tools for experimental therapy of paediatric neurodegenerative disorders causing childhood dementia in Europe and India

b.       Management of Gram negative multi-drug resistant infections

·         TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS DISEASES: TO CONFRONT MAJOR THREATS TO PUBLIC HEALTH

a.       ANTIMICROBIAL DRUG RESISTANCE: Multidisciplinary research on the evolution and transfer of antibiotic resistance

b.       EMERGING EPIDEMICS: Comprehensive control of Dengue fever under changing climatic conditions

·         TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES:

a.       Epidemiology and aetiology of infection-related cancers

 3. OPTIMISING THE DELIVERY OF HEALTHCARE TO EUROPEAN CITIZENS

·       HEALTH PROMOTION

a.       Developing and implementing methods for the transfer of research into policy in the fields of health promotion and disease prevention

b.       A road-map for mental health research in Europe

·       INTERNATIONAL PUBLIC HEALTH & HEALTH SYSTEMS

a.       Development and assessment of comprehensive and integrated interventions and programmes to improve reproductive health and health equity

b.       Building sustainable capacity for research for health and its social determinants in low and middle income countries

c.        Multilateral cooperation between Europe, Africa and Latin America on public health and health services research

4. OTHER ACTIONS ACROSS THE HEALTH THEME

a.       Networking of major research institutions to coordinate communication actions aimed at the media and the general public

b.       Targeting publication bias

c.        Linking EU and Latin American policy making institutions in the field of health research

d.       Organisation of supporting actions and events related to the Presidency of the European Union

·         RESPONDING TO EU POLICY NEEDS

a.       Investigator driven clinical trials on off-patent  medicines for children

b.       Adverse drug reaction research

c.       New methodologies for clinical trials in personalised medicine

For further information, please contact infonetwork@igcsas.it

Contribution for SMEs’ Research and Innovation Activities.

DEADLINE: SEPTEMBER 30^TH, 2010.

BENEFICIARIES:

A Eurostars project is collaborative, meaning it must involve at least two participants (legal entities) from two different Eurostars member countries:

• Main participant: one R&D-performing SME from a Eurostars member country (i.e. a SME that invests 10% or more of its turn-over or its full-time equivalent personal in research and development activities).

• Other entities: Any type of organisation (small and medium-sized enterprise, large company, university, research centre).
  
  ACTIVITIES:
  The activities to be implemented include:
  • Industrial research activities (planned research or critical investigations aimed at gaining new knowledge, which has to be exploited in order to develop new products, processes or services, or else to allow a significant improvement of the already existing ones).
    
  • Experimental development activities (acquisition, combination, structuring and use of the existing knowledge and skills: these can have either a scientific, technological or commercial nature, in order to produce plans, projects or designs for new products, processes or services, amended or enhanced).
  
  
  For further information, please contact infonetwork@igcsas.it
  
  

EU FUNDS FOR COOPERATION IN THE ICT SECTOR

  TOPICS

• Pervasive and Trustworthy Network and Service Infrastructures
• Cognitive Systems, Interaction, Robotics
• Components, systems, engineering
• Digital Libraries and Content
• Towards sustainable and personalised healthcare
• ICT for Mobility, Environmental Sustainability and Energy Efficiency
• ICT for Independent Living, Inclusion and Governance
• Future and Emerging Technologies (FET) 
  
  
  
  Target audience: research organizations, universities, industry, including SMEs, potential end-users) established in different EU Member States or Associated countries; furthermore, participation is open to any International European Interest Organisation or any legal entity established in an FP7 International Cooperation Partner Country.

For further information and news, contact us at infonetwork@igcsas.it

RESEARCHERS’ GRANT FUNDS

The European Research Council (ERC) funds every year excellent research projects in any scientific discipline aiming at broadening the scientific and technological knowledge ("frontier research"). Top researchers of any nationality and  from anywhere in the world can apply, as long as  their ERC project will be carried out in a public or private institution based in Europe ( EU Member State  or Associated Country ). The grants are for up to 5 years.

KEY POINTS:

• All fields of research are eligible
  
• All researchers are eligible: from any country in the world, regardless of nationality, type of institution, or age 
  
  
  
  Two types of ERC grants:

• Starting Grants, for the best researchers with 2 to 10 years of experience after their PhD;
  
• Advanced Grants, for top research leaders, with at least 10 years of experience and significant research achievements
  

• Attractive long-term funding: each project can receive up to 2 Million € (for Starting Grants) or up to 3.5 Million € (for Advanced Grants), for up to 5 years
  
• Principal Investigators and their research team are supported: no trans-national partnerships nor consortia are required
  

 

The ERC has yearly calls for proposals covering all scientific fields: Life Sciences, Social Sciences and Humanities, Physical Science and Engineering

For further information and news, contact us at infonetwork@igcsas.it